ALPHA TAU MEDICAL LTD.

Analyst Reco. Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-16 EDT			5-day change	1st Jan Change
2.67 ^USD	+0.75%		+10.79%	-11.30%

05-06	Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow	CI
03-07	Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Alpha Tau Medical's Price Target to $8 From $12, Keeps Overweight Rating	11-17	MT
HC Wainwright Starts Alpha Tau Medical at Buy With $9 Price Target	23-04-24	MT
Piper Sandler Adjusts Alpha Tau Medical's Price Target to $12 From $19, Keeps Overweight Rating	22-11-23	MT
Cantor Fitzgerald Initiates Alpha Tau Medical at Overweight with $20 Price Target	22-04-14	MT
Piper Sandler Starts Alpha Tau Medical at Overweight With $19 Price Target	22-04-08	MT
Citigroup Initiates Alpha Tau Medical at Buy With $21 Price Target	22-04-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW